{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/mortons-neuroma/management/management/","result":{"pageContext":{"chapter":{"id":"71b7c020-9e00-52e0-89f8-7dad624cea7a","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field aa12842a-984a-4279-ae4e-242006c4cb4a --><h2>Scenario: Management</h2><!-- end field aa12842a-984a-4279-ae4e-242006c4cb4a -->","summary":"Covers the primary care management of Morton's neuroma and a brief discussion of options that may be available in secondary care if referral is required.","htmlStringContent":"<!-- begin item 9bcf2326-6f20-4316-ab7e-c768e299cc70 --><!-- begin field 011c9df5-0475-494b-bbfc-acbc015767a4 --><p>From age 16 years onwards.</p><!-- end field 011c9df5-0475-494b-bbfc-acbc015767a4 --><!-- end item 9bcf2326-6f20-4316-ab7e-c768e299cc70 -->","topic":{"id":"c4ebddd3-af48-5e8f-8ed1-2aa76e4070b1","topicId":"9c31e668-1581-468d-96ce-d99c2ab7aafd","topicName":"Morton's neuroma","slug":"mortons-neuroma","lastRevised":"Last revised in September 2016","chapters":[{"id":"6b4bc981-9cba-54b9-a87e-957a4ba57063","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"99c0e452-b2cc-5886-a9d5-42668ea2848b","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"e9621e25-5b00-55db-8ce0-dac8a32d6e79","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"0778b768-ea67-588d-a616-1e8395dbc885","slug":"changes","fullItemName":"Changes"},{"id":"28539e40-1bb1-5637-9513-11f21e7ec437","slug":"update","fullItemName":"Update"}]},{"id":"7b0d11fa-c26c-56a1-b4a4-06066bd88dd5","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"1bbe8a45-c581-593c-ac16-b8ee44b7ef1c","slug":"goals","fullItemName":"Goals"},{"id":"c8d77046-8667-5a33-864c-7a428a7daac5","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"84bb4d88-4dc9-5852-b1f5-dc257ef000be","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f5e1c977-5bac-5472-819c-aa3b1384131c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"18d2ba4f-b8d8-5c6a-98de-428afdbad5d6","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b8fdf873-b643-5040-a135-509dbf09ff0a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f1228408-c50d-54be-8529-51d0e559cf81","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"694e194c-a565-5187-ae74-569bcc85ff8b","slug":"definition","fullItemName":"Definition"},{"id":"8a77b723-1740-585c-a700-efb1ef7e8a79","slug":"causes","fullItemName":"Causes"},{"id":"d16d1ed5-142d-55fe-8b6e-5a521a8d9949","slug":"prevalence","fullItemName":"Prevalence"},{"id":"89e18e15-c3b9-50c6-9103-876d17ded2e7","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"bcc77666-f42a-5651-9873-2e5b444c221f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"bcd4e399-0634-5e58-a78e-879494ccc88e","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"bae0d061-1470-55a9-a62b-af3e748e9746","slug":"investigations","fullItemName":"Investigations"},{"id":"eda5d38f-0ac3-58e9-8451-e66d6c910ef6","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d564918d-68a3-50a7-852a-b99cca2bfd1e","fullItemName":"Management","slug":"management","subChapters":[{"id":"71b7c020-9e00-52e0-89f8-7dad624cea7a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"3150c7ca-a619-5595-ab2a-0c6f1e29223d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"08c23e8c-75ad-5216-88b9-844bd1219048","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"88366459-46a4-5069-990a-87594f4f055a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"da35da28-44e3-5b98-ad77-55a820f87c55","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a4598807-62a8-5379-a81d-f17dee67d032","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6cabbcb4-2be8-54ac-94dd-60a42359c721","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"731a622f-9c34-59de-b09c-49032e2e130b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6768375b-6e33-5079-bbab-ee2de85785b9","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d564918d-68a3-50a7-852a-b99cca2bfd1e","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"cbc1765f-9b57-519f-99ad-49ab20cf7353","slug":"management-of-mortons-neuroma","fullItemName":"Management of Morton's neuroma","depth":3,"htmlHeader":"<!-- begin field 6a7919b9-2dec-4418-a6ee-7e85e265780d --><h3>Management of Morton's neuroma</h3><!-- end field 6a7919b9-2dec-4418-a6ee-7e85e265780d -->","summary":null,"htmlStringContent":"<!-- begin item b3d08c0c-0ba4-4a70-a9cf-d0c2d24e3ce4 --><!-- begin field cddd47e2-68c0-435e-91ef-8410624ed806 --><ul><li>Advise the person:<ul><li>To avoid high heels, and shoes with a constricting toe box or thin soles to reduce pressure on the forefoot.</li><li>To use a metatarsal pad: <ul><li>These are available over-the-counter.</li><li>The pad should be placed just proximal to the metatarsal heads to reduce pressure from the nerve.</li></ul></li></ul></li><li>Consider offering nonsteroidal anti-inflammatory drugs if necessary. For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a>.</li><li>Offer written information on <a href=\"https://www.nhs.uk/conditions/mortons-neuroma/\" data-hyperlink-id=\"c4c5ee57-3ca2-49e8-a931-aa5600ab3d96\">Morton's neuroma</a>, such as that available from the NHS.  </li><li>If symptoms persist despite 3 months of footwear modifications and using metatarsal pads:<ul><li>Refer the person to an orthotist for a metatarsal dome orthotic.</li><li>If referral to orthotics is not available, or if symptoms persist despite a trial of an orthotic device:<ul><li>Refer to an orthopaedic surgeon with a special interest in the foot, a musculoskeletal clinic, or a podiatric surgeon (depending on local policy and service provision) for consideration of specialist treatments such as corticosteroid injection or surgery. </li></ul></li></ul></li></ul><!-- end field cddd47e2-68c0-435e-91ef-8410624ed806 --><!-- end item b3d08c0c-0ba4-4a70-a9cf-d0c2d24e3ce4 -->","subChapters":[{"id":"112c1b33-59ee-545d-bcc6-b5c47c7b35fd","slug":"specialist-treatments","fullItemName":"Specialist treatments","depth":4,"htmlHeader":"<!-- begin field a70a32ae-76ac-4738-b1bb-cb47b9c40977 --><h4>Specialist treatments</h4><!-- end field a70a32ae-76ac-4738-b1bb-cb47b9c40977 -->","summary":null,"htmlStringContent":"<!-- begin item d063c273-ecd6-45ba-b65c-24dd2545076b --><!-- begin field 4cf979ad-3bfa-4b35-8105-2e403fb201ec --><ul><li>Treatments that may be offered in secondary care include:<ul><li>Corticosteroid injection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Adams, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Summers, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Adams et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Peters et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Thomas et al, 2009a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Pomeroy et al, 2015</a>].</li><li>Neurectomy of the involved interdigital nerve and neuroma  [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Thomas et al, 2009a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Adams, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Nazarko, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Association of Extremity Nerve Surgeons, 2014</a>].<ul><li>The affected portion of nerve is removed.</li></ul></li><li>Decompression of the interdigital nerve by deep transverse metatarsal ligament release, with or without neurolysis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Briggs, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Thomas et al, 2009a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Nazarko, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Association of Extremity Nerve Surgeons, 2014</a>]. <ul><li>Compression of the nerve is reduced by dividing the deep transverse inter-metatarsal ligament.</li></ul></li><li>Guided alcohol injections [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Adams, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Summers, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Peters et al, 2011</a>].</li></ul></li></ul><!-- end field 4cf979ad-3bfa-4b35-8105-2e403fb201ec --><!-- end item d063c273-ecd6-45ba-b65c-24dd2545076b -->","subChapters":[]},{"id":"ffefc1e7-51fd-58bd-b8aa-548117721a37","slug":"basis-for-recommendation-862","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 03db545b-d17d-4b29-9e8e-8021abf0e595 --><h4>Basis for recommendation</h4><!-- end field 03db545b-d17d-4b29-9e8e-8021abf0e595 -->","summary":null,"htmlStringContent":"<!-- begin item 862819a8-b705-400b-98fd-6611a6651da6 --><!-- begin field 25cc16b4-53dc-463f-a2c5-d88634da465c --><h5>Footwear modification and metatarsal pads</h5><ul><li>Expert opinion based on review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Woodburn and Helliwell, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Adams, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Summers, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Adams et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Peters et al, 2011</a>]<strong>, </strong>a clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Association of Extremity Nerve Surgeons, 2014</a>], a clinical consensus document [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Thomas et al, 2009a</a>], and evidence from two case series [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Bennett et al, 1995</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Saygi et al, 2005</a>] is that footwear modifications and metatarsal pads should be first-line treatment. </li><li>The recommendation to avoid shoes with high heels or a constricting toe box is also based on expert opinion from guidelines issued by NHS Scotland [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">NHS Scotland, 2005</a>] and expert opinion from a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Baquie et al, 2009</a>]. The recommendation to avoid thin-soled shoes is based on the expert opinion of a previous reviewer of this CKS topic.</li><li>A Cochrane systematic review found insufficient evidence to confirm the effectiveness of supinatory insoles for Morton's neuroma [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Thomson, 2004</a>]. Supinatory insoles are not mentioned as a current treatment option in a clinical practice guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Association of Extremity Nerve Surgeons, 2014</a>].</li></ul><h5>Nonsteroidal anti-inflammatory drugs</h5><ul><li>CKS identified no evidence to support the use of nonsteroidal anti-inflammatory drugs in the treatment of Morton's neuroma. However their use is supported by expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Adams, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Summers, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Nazarko, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Peters et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Pomeroy et al, 2015</a>] and previous reviewers of this CKS topic consider that they may have limited use in some people. </li></ul><h5>Written information</h5><ul><li>This recommendation is based on what CKS considers to be good clinical practice.</li></ul><h5>Referral following conservative treatment</h5><ul><li>CKS found no evidence on the timescale of referral if conservative treatment is not effective. The recommendation to try footwear modifications and use metatarsal pads for 3 months prior to referral is based on the expert opinion of previous reviewers of this CKS topic.</li></ul><h5>Referral to an orthotist for a metatarsal dome orthotic</h5><ul><li>The recommendation to refer to an orthotist for a metatarsal dome orthotic if footwear modifications and metatarsal pads have not been successful is based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Woodburn and Helliwell, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Adams, 2010</a>] and expert opinion from previous reviewers of this CKS topic.</li></ul><h5>Referral to an orthopaedic surgeon with a special interest in the foot, a musculoskeletal clinic, or a podiatric surgeon</h5><ul><li>The recommendation to refer people with persistent symptoms for consideration of specialist treatments is based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Adams, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">Peters et al, 2011</a>], NHS Scotland guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mortons-neuroma/references/\">NHS Scotland, 2005</a>], and what CKS considers to be good clinical practice.</li></ul><!-- end field 25cc16b4-53dc-463f-a2c5-d88634da465c --><!-- end item 862819a8-b705-400b-98fd-6611a6651da6 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}